On this question;
"CR or distribution agreement before production? "
Fairly certain there is enough product in storage for a year, or close to that, of sales in the USA when it comes to Ryoncil for Pediatric aGVHD. It also sounds rather like stock on hand at some institutions goes from compassionate use to paid use pending approval.
- Forums
- ASX - By Stock
- MSB
- Undervalued Fair value $0.85
Undervalued Fair value $0.85, page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 539 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 10643 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 452 | 1.215 |
2 | 539 | 1.190 |
2 | 657 | 1.180 |
1 | 20000 | 1.170 |
4 | 14659 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 8788 | 2 |
1.145 | 1000 | 1 |
1.150 | 10000 | 1 |
1.160 | 24152 | 5 |
1.165 | 2100 | 2 |
Last trade - 09.51am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online